NCT00261560View on ClinicalTrials.gov

A Safety and Effectiveness Study of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Pain Associated With Ankle Sprains.

PHASE4CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

Not specified

Study Completion Date

February 29, 2004

Conditions
Sprains and StrainsPain
Interventions
DRUG

acetaminophen

All Listed Sponsors
lead

Johnson & Johnson Consumer and Personal Products Worldwide

INDUSTRY